Expert Series: Stride Study for PMM Patients
Join MitoAction and Dr. Alex Dorenbaum, Chief Medical Officer at Reneo Pharmaceuticals, as they discuss the Stride Study results for mavodelpar in Primary Mitochondria Myopathy. This will be a roundtable discussion format so patients and clinicians can ask their questions.
